Learn more about whether Amneal Pharmaceuticals, Inc. or Ocular Therapeutix, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for ...

Nicox and Kowa entered into an agreemen in February 2024, in which Kowa was granted exclusive Japanese rights to develop and ...

Optometrists can safely perform selective laser trabeculoplasty, with 2.2% of eyes experiencing adverse events, according to ...

Press Release Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan Exclusive Japanese partner Kowa has ...

A new study published in the Nature Scientific Reports showed that compared to kidney recipients who got preemptive transplants, individuals who experienced dialysis prior to transplantation are ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...

Meredith R. Klifto, MD, is an assistant professor of ophthalmology at the University of North Carolina School of Medicine, Chapel Hill. As a board-certified ophthalmologist, she specializes in ...

A review reveals dangerous vitamin deficiencies post-bariatric surgery, highlighting the need for improved follow-up to ...

These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold ...